Plasma from haemophilia A dogs with known Bethesda inhibitor (BIU) titres that crossreact with and inhibit human FVIII was used as a positive control, and plasma from dogs without inhibitors was assayed concurrently as a negative control for comparative analysis. The gene discussed is F8; the disease is hemophilia A.